Intralipid Shortage Update: What Patients Need to Know in 2026

If you're on home parenteral nutrition (PN) or your provider has prescribed Intralipid, you may have heard about supply disruptions and wondered whether this drug is currently in short supply. This guide cuts through the noise to give you the current picture on Intralipid availability in 2026 — and what to do if your pharmacy can't fill your prescription.

Is Intralipid in a National Shortage in 2026?

As of 2026, Intralipid is not listed on the FDA's national Drug Shortage Database as a currently short drug. Fresenius Kabi, the manufacturer, has maintained production. However, the absence of a national shortage designation does not mean every patient will have seamless access. Here is what actually matters for patients:

Localized supply disruptions can and do occur at the home infusion pharmacy level, even without a national shortage.

Refrigerated IV products require more complex logistics, and shipping or storage failures can create temporary outages.

Home infusion pharmacies sometimes face their own stock challenges separate from national supply trends.

Historical Context: When IV Products Have Faced Shortages

Understanding the history of IV nutritional product shortages helps explain why vigilance matters for Intralipid patients. The broader IV solutions supply chain is fragile:

2017-2018: Hurricane Maria devastated Puerto Rico, disrupting IV saline and dextrose production from Baxter's facilities, causing widespread IV solution shortages across the US.

2024: Hurricane Helene damaged Baxter's North Carolina manufacturing plant, triggering critical shortages of IV fluids including dextrose, peritoneal dialysis solutions, and Lactated Ringer's.

Ongoing: The FDA and ASHP consistently note that sterile injectable drugs — including IV nutritional products — are among the most shortage-prone categories. As of September 2024, 277 drugs were in active shortage nationally, with 50% lasting 2+ years.

While Intralipid (Fresenius Kabi) was not directly affected by the Hurricane Helene disruptions — which primarily impacted Baxter — these events highlight how vulnerable the IV product supply chain is. A disruption at Fresenius Kabi's facilities could similarly impact Intralipid supply.

Why Intralipid Is Particularly Vulnerable to Access Issues

Even without an active national shortage, patients face access challenges with Intralipid because:

Single-source product. Intralipid has no FDA-approved generic. If Fresenius Kabi faces supply issues, there is no generic manufacturer to fill the gap. Alternative brands (SMOFlipid, Clinolipid) require a prescription change.

Specialty distribution. Intralipid only flows through specialty channels — hospital and home infusion pharmacies — which have narrower supply networks than retail pharmacies.

Cold-chain requirements. Intralipid must be stored below 25°C and cannot be frozen. Once removed from refrigeration, PN admixtures must be infused within 24 hours. Any break in the cold chain results in product waste.

What to Do If Your Pharmacy Can't Fill Your Intralipid Prescription

Call your nutrition support team immediately. They can authorize a clinical switch to SMOFlipid, Clinolipid, or another alternative, and can contact your home infusion pharmacy on your behalf.

Contact other home infusion pharmacies. National providers like Option Care Health and Coram CVS may have stock when your current pharmacy doesn't.

Use medfinder to check availability.medfinder calls pharmacies near you to find which ones have Intralipid in stock and can fill your prescription — saving you hours of calling.

Check the FDA Drug Shortage Database. Visit accessdata.fda.gov to verify whether a formal national shortage has been declared for Intralipid or IV lipid emulsions broadly.

Do not skip doses without medical guidance. For patients dependent on PN as their primary or sole nutrition source, stopping Intralipid without medical supervision can cause serious harm, including essential fatty acid deficiency and malnutrition.

How Patients Can Monitor Intralipid Availability

The best way to stay ahead of Intralipid supply issues is to be proactive. Reorder your medication 7-10 days before you need it. Maintain an open relationship with your home infusion pharmacy pharmacist. And if you're ever in doubt about supply, use tools like medfinder's pharmacy locator to check real-time availability at multiple pharmacies at once.